HCPCS Level II Code Lookup
Look up official HCPCS Level II codes for products, supplies, drugs, equipment and services, or browse by letter family below.
- Current release
- October 2026 effective October 1, 2026
- Active codes
- 7,448 active codes
- Maintainer
- Maintained by CMS
Browse by Letter Family
8,769 codes, grouped by their leading letter.
M
- M1405 Patients with recurrence/disease progression
- M1406 Patients who leave the practice during the follow-up period
- M1407 Patients who died during the follow-up period
- M1408 Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer
- M1409 Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis
- M1410 Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis
- M1411 Currently on first-line immune checkpoint inhibitors without chemotherapy
- M1412 Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement
- M1413 Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
- M1414 Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)
- M1415 Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
- M1416 Patient received hospice services any time during the performance period
- M1417 Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
- M1418 Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician
- M1419 Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
- M1420 Complete ophthalmologic care mips value pathway
- M1421 Dermatological care mips value pathway
- M1422 Gastroenterology care mips value pathway
- M1423 Optimal care for patients with urologic conditions mips value pathway
- M1424 Pulmonology care mips value pathway
- M1425 Surgical care mips value pathway
- M1426 Encounters conducted via telehealth
- M1427 Documentation of medical reason(s) for performing a bone scan (including documented pain related to prostate cancer, salvage therapy, other medical reasons)
- M1428 Patients who have bilateral absence of eyes any time during the patient's history through the end of the measurement period
- M1429 Retinal exam finding with evidence of retinopathy in left, right or both eyes with severity level documented
- M1430 Retinal exam finding without evidence of retinopathy in both eyes with severity level documented (in measurement year or in the prior year)
- M1431 Encounters conducted via telehealth
- M1432 Encounters conducted via telehealth
- M1433 Patient on oral chemotherapy on or within 30 days before denominator eligible encounter
- M1434 Patient on oral chemotherapy on or within 30 days after denominator eligible encounter
- M1435 Patient on oral chemotherapy during the performance period
- M1436 Encounters conducted via telehealth
- M1437 Encounters conducted via telehealth
- M1438 Time last known well to hospital arrival less than or equal to 3.5 hours (<= 210 minutes)
- M1439 Significant ocular conditions that impact the visual outcome of surgery
- M1440 Encounters conducted via telehealth
- M1441 Encounter corresponds to initial diagnosis of sleep apnea or first contact with sleep apnea diagnosed patient
- M1442 Encounters conducted via telehealth
- M1443 Encounters conducted via telehealth
- M1444 Delivery at < 39 weeks of gestation
- M1445 Postpartum care visit before or at 12 weeks of giving birth
- M1446 Patients who died any time prior to the end of the measure assessment period
- M1447 Patients with an active diagnosis of bipolar disorder any time prior to the end of the measure assessment period
- M1448 Patients with an active diagnosis of personality disorder any time prior to the end of the measure assessment period
- M1449 Patients with an active diagnosis of schizophrenia or psychotic disorder any time prior to the end of the measure assessment period
- M1450 Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period
- M1451 Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period
- M1452 Patient ever had a diagnosis of dementia
- M1453 Patients with a pre-operative visual acuity better than 20/40
- M1454 New cied
- M1455 Replaced or revised cied
- M1456 Patient had a heart transplant
- M1457 Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period
- M1458 Patient died prior to the end of the performance period
- M1459 Patient was in hospice or receiving palliative care services at any time during the performance period
- M1460 Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure
- M1461 Patient diagnosis for chronic hepatitis c
- M1462 Patients with clinical indications for imaging of the head
- M1463 Documentation of at least two attempts to follow up with patient within 180 days of treatment
- M1464 No documentation of at least two attempts to follow up with patient within 180 days of treatment
- M1465 Patient follow up more than 180 days after treatment
- M1466 Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure
- M1467 Patients with an existing diagnosis of lynch syndrome
- M1468 Patient received recommended doses of hepatitis b vaccination based on age
- M1469 Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period
- M1470 Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine)
- M1471 Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules
- M1472 Patient did not receive recommended doses of hepatitis b vaccination based on age
- M1473 Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
- M1474 Patients with diagnosis of dementia
- M1475 Patients with diagnosis of huntington's disease
- M1476 Patients with diagnosis of cognitive impairment or alzheimer's disease
- M1477 Diagnosis of delirium
- M1478 Psychoactive substance abuse
- M1479 Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
- M1480 Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders
- M1481 Patients receiving hospice or palliative care or who died during the measurement period
- M1482 Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period
- M1483 Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period
- M1484 Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)
- M1485 Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period
- M1486 Patients admitted to a skilled nursing facility (snf) during the period of evaluation
- M1487 Patients in hospice in the year before or during the period of evaluation
- M1488 Patients with a diagnosis for dementia in the year before or during the period of evaluation
- M1489 Patient status documented
- M1490 Patient status not documented
- M1491 Receiving esrd mcp dialysis services by the provider during the performance period
- M1492 Patients who did not report a fall
- M1493 Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy)
- M1494 Patients that reported a fall since the last visit
- M1495 Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall
- M1496 Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls
- M1497 Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy)
- M1498 Diagnostic radiology mips value pathway
- M1499 Interventional radiology mips value pathway
- M1500 Neuropsychology mips value pathway
- M1501 Pathology mips value pathway
- M1502 Podiatry mips value pathway
- M1503 Vascular surgery mips value pathway